Need Help? Chat Now With a Live Representative!

Press Releases

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

Atlantic Research Group, a pioneer in the immunology space since 2004, proudly announces the FDA approval of Bivigam for pediatric […]

March 18, 2024
ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

CHARLOTTESVILLE, Va., April 11, 2023 — Victoria Allgood, PhD, has joined Atlantic Research Group (ARG) as Vice President, Scientific Affairs, […]

April 11, 2023
Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

CHARLOTTESVILLE, Va., March 1, 2023 — Jeffrey H. Lawson, MD, PhD has joined Atlantic Research Group (ARG) as Chief Medical […]

March 1, 2023
Atlantic Research Group Opens Office in Munich

Atlantic Research Group Opens Office in Munich

CHARLOTTESVILLE, Va. and MUNICH, June 8, 2022 — Atlantic Research Group (ARG), a full-service global contract research organization (CRO), has […]

June 7, 2022
ARG One of 16 Companies Selected to Participate in Virginia Trade Program

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

The Virginia Economic Development Partnership (VEDP) recently announced in a press release the “acceptance of 16 companies into its two-year […]

January 19, 2022
ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv

ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv

Our partner Cytokinetics, Incorporated announced August 2, 2021 that COURAGE-ALS, a Phase 3 clinical trial of Reldesemtiv in patients with ALS, is open to enrollment.

August 11, 2021
GO TO TOP